title: [Trombopag for chronic immune thrombocytopenia in a patient previously treated with romiplostim].
authors.forename: B
authors.initials: B
authors.lastname: Rodríguez Vargas
authors.forename: J
authors.initials: J
authors.lastname: Serna Pérez
authors.forename: T
authors.initials: T
authors.lastname: Bermejo Vicedo
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use*; D001803:Blood Transfusion; D003131:Combined Modality Therapy; D004351:Drug Resistance; D057915:Drug Substitution; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D011720:Pyrazoles / Q000627:therapeutic use*; D011961:Receptors, Fc / Q000627:therapeutic use; D053628:Receptors, Thrombopoietin / Q000819:agonists; D011993:Recombinant Fusion Proteins / Q000494:pharmacology / Q000627:therapeutic use; D000069283:Rituximab; D012595:Scleroderma, Systemic / Q000150:complications; D013926:Thrombopoietin / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D001565:Benzoates; D006834:Hydrazines; D016756:Immunoglobulins, Intravenous; D011720:Pyrazoles; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; C082218:MPL protein, human; D000069283:Rituximab; D013926:Thrombopoietin; C488777:romiplostim; C520809:eltrombopag; D011241:Prednisone